4//SEC Filing
Posner Christopher 4
Accession 0001209191-23-007170
CIK 0001346830other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:38 PM ET
Size
5.2 KB
Accession
0001209191-23-007170
Insider Transaction Report
Form 4
Posner Christopher
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Stock
2023-02-02$11.80/sh−4,191$49,454→ 182,370 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on November 3, 2021 and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001748265
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:38 PM ET
- Size
- 5.2 KB